Company Filing History:
4 out of 22 
1 out of 1,271 
1 out of 1,080 
Years Active: 1994-1996
Title: Innovations by Charles T Tackney: Pioneering Contributions in Biomedicine
Introduction
Charles T Tackney, an inventive force from Brooklyn, NY, has made significant strides in the realm of biotechnology. With a portfolio comprising five patents, Tackney has focused on the development of innovative solutions, particularly in the fields of recombinant DNA technology and immunology.
Latest Patents
Two notable patents showcase his recent contributions:
1. **Recombinant Hybrid Porin Epitopes** - This invention introduces a polypeptide that is non-toxic in E. coli. The polypeptide consists of antigenic sequences derived from P.IA and P.IB of N. gonorrhoeae, and it is fused to a carrier peptide, paving the way for advancements in vaccine development.
2. **Method of Making Cysteine Depleted IL-6 Muteins** - Tackney's work on IL-6 muteins involves the preparation of truncated forms using recombinant DNA techniques. In this innovation, critical cysteine residues have been modified while retaining others, resulting in molecules that maintain biological activity comparable to native IL-6.
Career Highlights
Throughout his career, Charles Tackney has contributed to prestigious organizations such as ImClone Systems, Inc. and the University of North Carolina at Chapel Hill. His work in these institutions has fostered advancements in therapeutic treatments and biotechnology applications, further establishing his reputation as a leading inventor in his field.
Collaborations
Tackney has collaborated with notable colleagues, including Susan M Skelly and John N Snouwaert. These partnerships have facilitated the exchange of ideas and accelerated innovations, highlighting the importance of collaborative efforts in scientific progress.
Conclusion
Charles T Tackney's inventive contributions have had a substantial impact on biomedicine. With his cutting-edge patents and collaborations, he continues to push the boundaries of science, paving the way for future innovations. As he remains active in his field, the scientific community eagerly anticipates his next groundbreaking endeavors.